Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 12/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 12/20 | 0.53 |
| ▸ | ABCC1 | P33527 | 11/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MET | P08581 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9758206 | 1.00 | ABCB1 (0.53) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL16240912 | 0.84 | KDM4E (0.50) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL16240911 | 0.84 | KDM4E (0.50) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL6698837 | 0.83 | ALDH1A1 (0.44) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL20335193 | 0.83 | ALDH1A1 (0.44) | ABCB1ABCG2ABCC1KDM4EALDH1A1 | |
| SCHEMBL17947814 | 0.82 | KDM4E (0.49) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL20335167 | 0.82 | KDM4E (0.49) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL17459720 | 0.79 | ALOX5 (0.67) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL17459718 | 0.79 | ALOX5 (0.67) | ABCB1ABCG2ABCC1ALOX5KDM4E | |
| SCHEMBL9119106 | 0.77 | ABCB1 (0.56) | ABCB1ABCG2ABCC1ALOX5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-3204887-A | — | — | None | — | — | JP | disclosed |
| US-20240139085-A1 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2024-05-02 | — | — | US | disclosed |
| EP-4296232-A1 | SURFACE-MODIFIED ZINC OXIDE PAPRTICLES, DISPERSION LIQUID, COSMETIC PREPARATION, AND METHOD FOR PRODUCING SURFACE-MODIFIED ZINC OXIDE PARTICLES | Sumitomo Osaka Cement Co., Ltd. (JP) | 2023-12-27 | — | — | EP | disclosed |
| EP-4253323-A1 | ZINC OXIDE POWDER, DISPERSION LIQUID, COATING MATERIAL, AND COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2023-10-04 | — | — | EP | disclosed |
| EP-4253322-A1 | ZINC OXIDE POWDER, LIQUID DISPERSION, COATING MATERIAL, AND COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2023-10-04 | — | — | EP | disclosed |
| US-20230263708-A1 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION SOLUTION, AND COSMETIC | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230218488-A1 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, LIQUID DISPERSION, AND COSMETIC | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230136530-A1 | SURFACE-TREATED METAL OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC AND METHOD FOR PRODUCING SURFACE-TREATED METAL OXIDE PARTICLES | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4144695-A1 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, DISPERSION SOLUTION, AND COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2023-03-08 | — | — | EP | disclosed |
| EP-4144696-A1 | SURFACE-MODIFIED ZINC OXIDE PARTICLES, LIQUID DISPERSION, AND COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2023-03-08 | — | — | EP | disclosed |
| WO-2021066098-A1 | W/O/W EMULSION COMPOSITION | 株式会社 資生堂 | 2021-04-08 | — | — | WO | disclosed |
| WO-2020067406-A1 | SURFACE-TREATED METAL OXIDE PARTICLES, LIQUID DISPERSION, COMPOSITION, COSMETIC, AND METHOD FOR PRODUCING SURFACE-TREATED METAL OXIDE PARTICLES | 住友大阪セメント株式会社 | 2020-04-02 | — | — | WO | disclosed |
| WO-2020067417-A1 | SURFACE-TREATED METAL OXIDE PARTICLES, LIQUID DISPERSION, COSMETIC, AND METHOD FOR PRODUCING SURFACE-TREATED METAL OXIDE PARTICLES | 住友大阪セメント株式会社 | 2020-04-02 | — | — | WO | disclosed |
| EP-3342755-B1 | ZINC OXIDE POWDER | SUMITOMO OSAKA CEMENT CO LTD (JP) | 2020-02-12 | — | — | EP | disclosed |
| US-20180256461-A1 | ZINC OXIDE POWDER, DISPERSION, COMPOSITION, AND COSMETIC | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2018-09-13 | — | — | US | disclosed |
| EP-3342755-A1 | ZINC OXIDE POWDER, DISPERSION, COMPOSITION, AND COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2018-07-04 | — | — | EP | disclosed |
| EP-3252011-A1 | ZINC OXIDE POWDER, DISPERSION, PAINT, COSMETIC | Sumitomo Osaka Cement Co., Ltd. (JP) | 2017-12-06 | — | — | EP | disclosed |
| US-20160221835-A1 | ZINC OXIDE POWDER, DISPERSION, PAINT, AND COSMETIC MATERIAL | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9403691-B1 | Zinc oxide powder, dispersion, paint, and cosmetic material | SUMITOMO OSAKA CEMENT CO., LTD. (JP) | 2016-08-02 | — | — | US | disclosed |
| JP-H03204887-A | PRODUCTION OF SILICONE BASED CONNAMIC ACID DERIVATIVE | SHISEIDO CO LTD | 1991-09-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230136530-A1 | SURFACE-TREATED METAL OXIDE PARTICLES, DISPERSION LIQUID, COSMETIC AND METHOD FOR PRODUCING SURFACE-TREATED METAL OXIDE PARTICLES | CUTA, CD63, DSG1 | ABCB1 4130/4885ABCG2 4101/4885ABCC1 4459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.